Bio-Rad Laboratories (BIO) Gross Margin (2009 - 2026)
Bio-Rad Laboratories (BIO) reported Gross Margin of 52.25% for Q1 2026, down 2.0% year-over-year from 53.32% in Q1 2025, and up 4.93% quarter-over-quarter from 49.8% in Q4 2025.
Bio-Rad Laboratories (BIO) Gross Margin (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has 18 years of Gross Margin data on file, last reported at 52.25% in Q1 2026.
- Gross Margin for Q1 2026 came in at 52.25%, down 2.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 51.87% (down 161.0% YoY), and the FY2025 annual result was 51.87%, down 186.0% from the prior year.
- Gross Margin improved to 52.25% in Q1 2026 per BIO's latest filing, from 49.8% in the prior quarter.
- Over five years, Gross Margin peaked at 57.51% in Q1 2022 and troughed at 49.8% in Q4 2025.
- A 5-year average of 53.67% and a median of 53.36% in 2024 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2023: Gross Margin soared 240 bps in 2022, then tumbled 396 bps in 2023.
- A 5-year view of Gross Margin shows it stood at 54.37% in 2022, then slipped by 1 bps to 53.77% in 2023, then dropped by 5 bps to 51.24% in 2024, then slipped by 3 bps to 49.8% in 2025, then grew by 5 bps to 52.25% in 2026.
- Business Quant data shows BIO's Gross Margin at 52.25% in Q1 2026, 49.8% in Q4 2025, and 52.59% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 43.89% |
| 10 | Bio-Rad Laboratories | 7.62 Bn | 6.05 Bn | 309.40 Mn | 52.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.25% |
| Dec 31, 2025 | 49.80% |
| Sep 30, 2025 | 52.59% |
| Jun 30, 2025 | 52.99% |
| Mar 31, 2025 | 52.27% |
| Dec 31, 2024 | 51.24% |
| Sep 30, 2024 | 54.78% |
| Jun 30, 2024 | 55.61% |
| Mar 31, 2024 | 53.36% |
| Dec 31, 2023 | 53.77% |
| Sep 30, 2023 | 53.11% |
| Jun 30, 2023 | 53.22% |
| Mar 31, 2023 | 53.55% |
| Dec 31, 2022 | 54.37% |
| Sep 30, 2022 | 54.73% |
| Jun 30, 2022 | 57.16% |
| Mar 31, 2022 | 57.51% |
| Dec 31, 2021 | 54.57% |
| Sep 30, 2021 | 58.43% |
| Jun 30, 2021 | 56.03% |